Online inquiry

IVTScrip™ pSP6-VEE-mRNA-Anti-SAA1, NEOD-001 Vector   (CAT#: GTVCR-WQ2074MR)

This product GTVCR-WQ2074MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the SP6 promoter to efficiently generate mRNA ecoding antibody which targeting SAA1. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter SP6
Resistance Ampicillin
Species Chimeric; Humanized
RefSeq NM_000331.6
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 6288
UniProt ID P0DJI8
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pSP6-VEE-mRNA-Anti-SAA1, NEOD-001 Vector (GTVCR-WQ2074MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ1510MR IVTScrip™ pSP6-VEE-mRNA-Anti-IL13, IMA-638 Vector Vector IMA-638
GTVCR-WQ2348MR IVTScrip™ pT7-VEE-mRNA-Anti-LAG3, aLAG367 Vector Vector aLAG367
GTVCR-WQ1998MR IVTScrip™ pSP6-VEE-mRNA-Anti-GUCY2C, MLN2045 Vector Vector MLN2045
GTVCR-WQ2242MR IVTScrip™ pSP6-VEE-mRNA-Anti-PRLR, PR-1594804 Vector Vector PR-1594804
GTVCR-WQ1766MR IVTScrip™ pSP6-VEE-mRNA-Anti-PCSK9, LY-3015014 Vector Vector LY-3015014
GTVCR-WQ1207MR IVTScrip™ pT7-VEE-mRNA-Anti-CD19, FMC63 scFv-8A-F9Z CAR Vector Vector FMC63 scFv-8A-F9Z CAR
GTVCR-WQ2050MR IVTScrip™ pSP6-VEE-mRNA-Anti-CD274, MPDL3280A Vector Vector MPDL3280A
GTVCR-WQ719MR IVTScrip™ pT7-VEE-mRNA-Anti-LINGO1, BIIB-033 Vector Vector BIIB-033
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.